Original language | English |
---|---|
Pages (from-to) | 18-19 |
Journal | Multiple Sclerosis Journal |
Volume | 21 |
Publication status | Published - 2015 |
MS FIRST - utilising a drug safety module for use in MS clinical practice to evaluate lymphocyte reduction in fingolimod treatment over time, demographic predictors of lymphopenia and association with reported safety events
J. Haartsen, S. Agland, J. Baker, T. Burke, L. Rath, J. Lechner-Scott, B. Taylor, S. Vucic, M. Barnett, M. Slee, S. Hodgkinson, O. Skibina, A. Kermode, E. Butler, N. Shuey, C. Shaw, T. Hardy, I. L. Tan, H. Butzkueven, T. Spelman
Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review
1
Citation
(Web of Science)